WallStreetZenWallStreetZen

NASDAQ: STIM
Neuronetics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

STIM past revenue growth

How has STIM's revenue growth performed historically?
Company
9.42%
Industry
0.45%
Market
17.57%
STIM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
STIM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
STIM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

STIM earnings and revenue history

Current Revenue
$71.3M
Current Earnings
-$30.2M
Current Profit Margin
-42.3%

STIM Return on Equity

Current Company
-72.8%
Current Industry
-24%
Current Market
188%
STIM's Return on Equity (-72.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when STIM announces earnings.

STIM Return on Assets

Current Company
-29.3%
Current Industry
6.7%
STIM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

STIM Return on Capital Employed

Current Company
-25.79%
Current Industry
11.6%
STIM has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

STIM vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
STIM$71.35M-$22.76M-$30.19M+6.22%N/A
BDSX$49.09M-$37.10M-$52.15M+19.16%N/A
PRPH$44.38M-$14.83M-$16.78M+27.59%N/A
FONR$102.42M$25.75M$12.16M+4.06%-8.83%
NOTV$585.17M$59.57M-$33.21M+81.64%N/A
View Top Diagnostic & Research Stocks

STIM earnings dates

Next earnings date
May 7, 2024

Neuronetics Earnings & Revenue FAQ

What were STIM's earnings last quarter?

On Invalid Date, Neuronetics (NASDAQ: STIM) reported Q4 2023 earnings per share (EPS) of -$0.18, up 40% year over year. Total Neuronetics earnings for the quarter were -$5.38 million. In the same quarter last year, Neuronetics's earnings per share (EPS) was -$0.30.

If you're new to stock investing, here's how to buy Neuronetics stock.

What was STIM's earnings growth in the past year?

As of Q2 2024, Neuronetics's earnings has grown year over year. Neuronetics's earnings in the past year totalled -$30.19 million.

What is STIM's earnings date?

Neuronetics's earnings date is Invalid Date. Add STIM to your watchlist to be reminded of STIM's next earnings announcement.

What was STIM's revenue last quarter?

On Invalid Date, Neuronetics (NASDAQ: STIM) reported Q4 2023 revenue of $20.31 million up 11.63% year over year. In the same quarter last year, Neuronetics's revenue was $18.20 million.

What was STIM's revenue growth in the past year?

As of Q2 2024, Neuronetics's revenue has grown 9.42% year over year. This is 8.96 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 0.45%. Neuronetics's revenue in the past year totalled $71.35 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.